A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Clinical trial NCT06804824 · RECRUITING
Trial details
- NCT number
- NCT06804824
- Sponsor
- Vividion Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-25
- Primary completion
- 2027-08-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.